Letters to the Editor

Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund
Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund
Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund
Haematologica Early view May 31, 2022 https://doi.org/10.3324/haematol.2021.280303